Optical imaging for preterm birth assessment
View Patent ↗Methods, apparatuses, and systems for measuring collagen organization in the cervix, assessing the health of a woman's cervix (including a pregnant woman's cervix), characterizing the composition and structure of cervical tissue, and measuring preterm labor risk are provided. Polarization sensitive techniques and properties of cervical tissue, including birefringence, can be used. A method can include acquiring in vivo images of cervical tissue, applying Mueller matrix (MM) polarimetry (including 4×4 Mueller matrix polarimetry), and determining one or more parameters of the cervical tissue using the Mueller matrix (MM) polarimetry. The in vivo images can be analyzed and various parameters that characterize the cervical tissue can be determined. Graphs and maps of the cervical tissue can be generated for use as care provider tools.
1. A method for assessing structure, organization, and composition of cervical tissue, the method comprising:
imaging cervical tissue to acquire in vivo images of the cervical tissue;
analyzing the in vivo images of the cervical tissue using Mueller matrix (MM) polarimetry to generate data about the in vivo images of the cervical tissue; and
calculating pyridinoline cross-link concentration of the imaged cervical tissue and proteoglycan concentration of the imaged cervical tissue based on the data generated from the MM polarimetry.
2. The method of claim 1 , further comprising calculating collagen fiber angles or angle distributions relative to a cervical canal based on the data generated from the MM polarimetry.
3. The method of claim 1 , further comprising calculating cross-linking density between collagen fibrils based on the data generated from the MM polarimetry.
4. The method of claim 1 , further comprising calculating a dominant angle μ of collagen distribution based on the data generated from the MM polarimetry.
5. A method for assessing structure, organization, and composition of cervical tissue, the method comprising:
imaging cervical tissue to acquire in vivo images of the cervical tissue;
analyzing the in vivo images of the cervical tissue using Mueller matrix (MM) polarimetry;
decomposing the Mueller matrix to yield three canonical matrices including data about the in vivo images of the cervical tissue, the three canonical matrices including a diattenuator matrix MD, a depolarizing effects matrix MΔ, and a retarder matrix MR; and
calculating pyridinoline cross-link concentration of the imaged cervical tissue and proteoglycan concentration of the imaged cervical tissue based on the diattenuator matrix MD, the depolarizing effects matrix MΔ, and the retarder matrix MR.
6. The method of claim 5 , further comprising generating an orientation image of the cervical tissue based on the diattenuator matrix MD, the depolarizing effects matrix MΔ, and the retarder matrix MR.
7. The method of claim 5 , further comprising generating a histogram of an orientation image of the cervical tissue based on the diattenuator matrix MD, the depolarizing effects matrix MΔ, and the retarder matrix MR.
8. The method of claim 5 , further comprising
performing birefringence measurements of the cervical tissue to obtain first retardation images of the cervical tissue;
using polarization sensitive optical coherence tomography (PS-OCT) on the cervical tissue to obtain second retardation images of the cervical tissue, and
correlating the first retardation images obtained from the birefringence measurements with the second retardation images obtained using PS-OCT.
9. The method of claim 5 , further comprising calculating one or more parameters of depolarization Δ, linear retardance δ (birefringence), optical rotation R, slow axis orientation θ (the direction of polarization with the larger optical index), and diattenuation D based on the diattenuator matrix MD the depolarizing effects matrix MΔ, and the retarder matrix MR.
10. The method of claim 5 , further comprising calculating homogeneity using the retarder matrix MR based on the diattenuator matrix MD, the depolarizing effects matrix MΔ, and the retarder matrix MR.
11. The method of claim 5 , further comprising calculating collagen density based on the diattenuator matrix MD, the depolarizing effects matrix MΔ, and the retarder matrix MR.
12. The method of claim 11 , further comprising generating a collagen density map based on the diattenuator matrix MD, the depolarizing effects matrix MΔ, and the retarder matrix MR.
13. The method of claim 5 , the imaging of the cervical tissue to acquire the in vivo images of the cervical tissue being performed for 5 seconds or less.
14. A method for assessing structure, organization, and composition of cervical tissue, the method comprising:
imaging cervical tissue, using an imaging optical system comprising a colposcope, to acquire in vivo images of the cervical tissue;
analyzing the in vivo images of the cervical tissue using Mueller matrix (MM) polarimetry;
decomposing the Mueller matrix to yield three canonical matrices including data about the in vivo images of the cervical tissue, the three canonical matrices including a diattenuator matrix MD, a depolarizing effects matrix MΔ, and a retarder matrix MR;
calculating pyridinoline cross-link concentration of the imaged cervical tissue and proteoglycan concentration of the imaged cervical tissue based on the diattenuator matrix MD, the depolarizing effects matrix MΔ, and the retarder matrix MR;
calculating birefringence properties of the cervical tissue based on the diattenuator matrix MD, the depolarizing effects matrix MΔ, and the retarder matrix MR;
calculating collagen structure and organization including kinked structures and elongated structures based on the diattenuator matrix MD, the depolarizing effects matrix MΔ, and the retarder matrix MR;
calculating what percentage of collagen bundles have an elongated or a kinked appearance based on the diattenuator matrix MD, the depolarizing elects matrix MΔ, and the retarder matrix MR;
calculating angles of collagen fibers or a distribution of collage fibers angles relative to the cervical canal based on the diattenuator matrix MD, the depolarizing effects matrix MΔ, and the retarder matrix MR; and
calculating homogeneity of the cervical tissue based on the diattenuator matrix MD, the depolarizing elects matrix MΔ, and the retarder matrix MR.